Finally, due to the significant genetic heterogeneity within each tumour subtype, the analysis would be strengthened if other genetic alterations, for example, p53 and ATRX mutation, were considered, as these might play a role in IDH1 mutation associations. This evidence concerns the gene TP53 and neoplasm.